'A compelling profile for a Sepsis drug candidate' is FAR from affirming it works. It is about as positive as you could legally be about something that clearly doesn't work at that stage. Secondly, the data you screen shot is from the FIRST trial. So you have answered neither of my questions. Once again:
1. Show me data from the second trial.
2. Show me where they've said RCE327 can cure Sepsis.
Also, explain to me then why Sepsis has gone from being the companies primary goal and mission. To a dissapearing side note to topical, UTI and more....
- Forums
- ASX - By Stock
- Ann: Positive Phase II Data from Clinical Trial of R327 Gel
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.90%
!
31.0¢

'A compelling profile for a Sepsis drug candidate' is FAR from...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
29.0¢ | 32.8¢ | 29.0¢ | $78.39K | 251.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 916 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 114230 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.305 |
2 | 34804 | 0.295 |
2 | 12274 | 0.290 |
4 | 133518 | 0.285 |
10 | 238389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 4000 | 1 |
0.330 | 114230 | 1 |
0.350 | 31000 | 3 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 15.59pm 25/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online